Paul Stephen Oliver

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom.

The Roslin Institute conducts genetic research on animal and human health. It focuses on health and welfare of animals, and applications of basic animal sciences in human and veterinary medicine, the livestock industry and food security. The company was founded on April 1, 1993 and is headquartered in Midlothian, the United Kingdom.

Scottish Biomedical is a British company that specializes in biological research. The private company is based in Glasgow, UK.

Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK.

CXR Biosciences Ltd. provides drug development solutions and investigative toxicology services. Its drug development solutions include bioavailability, patient response variation, drug and drug interactions, drug reactions, toxicity, reactive metabolites, customized assay development, and anticancer drug development services. The firm serves pharmaceutical, biotech, agrochemical, consumer product, and fine chemical industries. The company was founded by Clifford Roy Elcombe and Roland Charles Wolf in December 2001 and is headquartered in Dundee, the United Kingdom.

Oxford Capital Partners LLP (Oxford Capital Partners) is a venture capital subsidiary of Oxford Capital Partners Holdings Ltd founded in 1999 by Tedd Mott and David Edward Christian Mott. The firm is headquartered in Oxford, United Kingdom.

Uniseed Management Pty Ltd. (Uniseed) is an independent Australian venture capital firm which was founded in 2000. The firm headquartered in Australia.

Molecular Vision Ltd. develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing. The company was founded by Donal D. C. Bradley in 2001 and is headquartered in York, the United Kingdom.

nanoTherics Ltd. develops and manufactures magnetic nanoparticle-based products. Its product range includes devices and reagents for magnet assisted transfection and delivery of biomaterials into cells for the life science research and development market as well as products for nanoparticle heating applications. The company was founded by Jon Dobson and Neil Farrow in 2007 and is headquartered in Newcastle-under-Lyme, the United Kingdom.

Part of Canon, Inc., Canon Medical Research Europe Ltd. is a British company founded in 2008 that provides digital imaging and scanning technologies to the medical sector. The company is based in Edinburgh, UK.

Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom.

Renephra Ltd. develops medical devices. Its is developing ground-breaking new approaches to dialysis treatment in end-stage renal disease by accessing the interstitial fluid in the skin. This new approach enables water and toxin removal in a non-invasive manner. The company was founded by Paul Brenchley and Sandip Mitra in 2009 and is headquartered in Manchester, the United Kingdom.

Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom.

Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom.

Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Trinity Investment Management Ltd. is a privately-owned, Great Britain-based real estate manager which was founded by Simon Hoad and Richard O’Boyle in 2012. Headquartered in London, the firm manages real estate assets for individual and institutional investors.

Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom.

Kinoxis Therapeutics Pty Ltd. engages in conducting biotechnology research. The company is headquartered in Camberwell, Australia.

Part of Nottingham Trent University, Nottingham Consultants Ltd. is a company founded in 1989 that offers information about the city of Nottingham, UK. The British company's description provides insights into the city's rich history, modern urban lifestyle, and various attractions, including museums, stately homes, and historical venues. The company also encourages visitors to bring their dogs along for an adventurous exploration of the city. The description also mentions the heathland of Sherwood, which is believed to be the result of woodland clearances dating back to Roman times. The company sends out newsletters to keep visitors informed about the city's events and attractions.

SecondPerspective Ltd. develops blood flow restriction training devices powered by artificial intelligence.

Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom.